Intellectual Property in the Pharmaceutical Sector of the EU

During the event, we will discuss:

• the evolution of legislation in the field of intellectual property and pharmaceuticals in the context of the development of the EU pharmaceutical industry;
  
• the main tools and mechanisms for protecting intellectual property rights in the pharmaceutical sector of the European Union;
  
• key trends in the reform of EU intellectual property legislation — in particular, the new «pharmaceutical package»;
  
• how the EU balances the protection of intellectual property rights, the promotion of generic production, and access to medicines.

Who will find it interesting:

• scientists and researchers developing new projects in biomedicine, pharmacy, or technology;
  
• medical professionals and bioethicists who seek to understand the legal aspects of their work;
  
• lawyers and patent attorneys working with intellectual property in the medical field;
  
• startups, innovators, and entrepreneurs developing health-related technologies;
  
• students and educators studying law, biology, medicine, technology, or ethics;
  
• anyone interested in how science and technology affect humanity, society, and human rights.

Moderator: Oksana Kashyntseva, PhD in Law, Associate Professor, Adviser to the Director of UANIPIO, National Consultant of UNDP in Ukraine, Consultant to the WHO Country Office in Ukraine, National Consultant of the Council of Europe, and Member of the European Association of Health Law.